Indiana, PA · MII 45 · thin · 2026-10-04
Practices in Indiana, PA with an obesity-medicine NPI listing, a name that says medical weight loss, or a CMS Open Payments record tied to a GLP-1 product from Novo Nordisk or Eli Lilly. A payment record is a proxy for prescribing, not a judgment about the practice.
22 listed (0 named, 22 specialty-only) · published price range $199–$1349/mo, compounded to brand cash price (source). Member ranges replace it at three reports.
Testosterone therapy clinics: 2 · Compounding pharmacies: 0 · Serious gyms: 0. See the Pennsylvania map.
It is the only public, business-level record of which practices have a relationship with the GLP-1 manufacturers. It is published by CMS under the Sunshine Act. We export the practice address only, never the recipient's name or the dollar amounts.
Compounding is allowed only while the FDA lists a shortage or for a documented patient-specific need, and only from a pharmacy licensed in your state (503A) or registered with the FDA (503B). Rules differ by state; our pharmacy layer asserts licensure only, never the legality of a particular prescription. A vial from a website with no pharmacy license is not a pharmacy product.
PhiladelphiaPittsburghErieAllentownReadingScrantonBethlehemLancasterJohnstownHarrisburgLanghorneAltoonaWest ChesterWilkes BarreButlerDu BoisWynnewoodWexfordMonroevilleYorkState CollegeCamp HillDoylestownBryn Mawr
Wayfinding, not a referral and not an endorsement. A business here has not been reviewed by us unless it also appears in the provider directory. Spot an error or a closure? Report it from the lookup. How this page is built: methodology.